| |
|
|
|
|
|
|
|||
|
A Rearden and P Chiu
The D antigen of the Rhesus blood group, an erythroid-specific cell surface
marker, is expressed by all morphologically recognizable human nucleated
red blood cell precursors including, in low density, the pronormoblast. The
object of the present study was to determine the expression of the D
antigen by committed erythroid progenitors. Under conditions that produced
complete inhibition of BFU-E and CFU-E by known cytotoxic antisera, no
significant inhibition was produced by anti-D. Use of anti-human IgG
(rabbit) to increase sensitivity and trypsinization to reveal cryptic Rh
determinants were both without inhibitory effect. Erythroid bursts and
colonies grew normally in methylcellulose that contained anti-D. The
addition of anti-D to day 7 BFU-E did not inhibit their proliferation to
mature bursts at day 14. These results suggest that the D antigen is not
expressed by human committed erythroid progenitor cells. The D antigen is
therefore an erythroid-specific differentiation marker, rather than an
erythroid- lineage-specific antigen. The development of expression of the D
antigen during erythropoiesis parallels that of band 3 protein, to which
anti-D has been reported to bind. Lack of Rh expression by committed
erythroid progenitors is consistent with the rarity of red cell aplasia in
Rhesus hemolytic disease of the newborn and in idiopathic and drug-induced
autoimmune hemolytic anemia in which the autoantibodies have apparent Rh
specificity. These results imply that Rh compatibility is not a
contraindication to human bone marrow transplantation.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1983 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||